These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 12431875

  • 21. Combined effects of meropenem and aminoglycosides on Pseudomonas aeruginosa in vitro.
    Nakamura A, Hosoda M, Kato T, Yamada Y, Itoh M, Kanazawa K, Nouda H.
    J Antimicrob Chemother; 2000 Dec; 46(6):901-4. PubMed ID: 11102407
    [Abstract] [Full Text] [Related]

  • 22. In vitro activity and killing effect of DX-8739, a new carbapenem, compared with those of meropenem and imipenem against multiresistant Pseudomonas aeruginosa.
    Giamarellos-Bourboulis EJ, Grecka P, Giamarellou H.
    Antimicrob Agents Chemother; 1995 Mar; 39(3):731-4. PubMed ID: 7793881
    [Abstract] [Full Text] [Related]

  • 23. Combination treatment with meropenem plus levofloxacin is synergistic against Pseudomonas aeruginosa infection in a murine model of pneumonia.
    Louie A, Liu W, VanGuilder M, Neely MN, Schumitzky A, Jelliffe R, Fikes S, Kurhanewicz S, Robbins N, Brown D, Baluya D, Drusano GL.
    J Infect Dis; 2015 Apr 15; 211(8):1326-33. PubMed ID: 25362196
    [Abstract] [Full Text] [Related]

  • 24. Activities of antibiotic combinations against resistant strains of Pseudomonas aeruginosa in a model of infected THP-1 monocytes.
    Buyck JM, Tulkens PM, Van Bambeke F.
    Antimicrob Agents Chemother; 2015 Jan 15; 59(1):258-68. PubMed ID: 25348528
    [Abstract] [Full Text] [Related]

  • 25. [Antimicrobial activity of carbapenems and the combined effect with aminoglycoside against recent clinical isolates of Pseudomonas aeruginosa].
    Tasaka K, Ishida A, Chinzei T.
    Jpn J Antibiot; 2002 Apr 15; 55(2):181-6. PubMed ID: 12071095
    [Abstract] [Full Text] [Related]

  • 26. An in vitro investigation of levofloxacin and ciprofloxacin against clinical isolates of Pseudomonas aeruginosa.
    Segatore B, Perilli M, Larosa M, Setacci D, Celenza G, Amicosante G.
    Int J Antimicrob Agents; 2007 Oct 15; 30(4):374-6. PubMed ID: 17659863
    [No Abstract] [Full Text] [Related]

  • 27. Risk factors and clinical significance of bacteremia caused by Pseudomonas aeruginosa resistant only to carbapenems.
    Lee CH, Su TY, Ye JJ, Hsu PC, Kuo AJ, Chia JH, Lee MH.
    J Microbiol Immunol Infect; 2017 Oct 15; 50(5):677-683. PubMed ID: 26188977
    [Abstract] [Full Text] [Related]

  • 28. Antibacterial activity of meropenem against Pseudomonas aeruginosa, including antibiotic-induced morphological changes and endotoxin-liberating effects.
    Trautmann M, Heinemann M, Zick R, Möricke A, Seidelmann M, Berger D.
    Eur J Clin Microbiol Infect Dis; 1998 Nov 15; 17(11):754-60. PubMed ID: 9923514
    [Abstract] [Full Text] [Related]

  • 29. In vitro synergy testing of levofloxacin, ofloxacin, and ciprofloxacin in combination with aztreonam, ceftazidime, or piperacillin against Pseudomonas aeruginosa.
    Pendland SL, Messick CR, Jung R.
    Diagn Microbiol Infect Dis; 2002 Jan 15; 42(1):75-8. PubMed ID: 11821176
    [Abstract] [Full Text] [Related]

  • 30. Activity of meropenem with and without ciprofloxacin and colistin against Pseudomonas aeruginosa and Acinetobacter baumannii.
    Pankuch GA, Lin G, Seifert H, Appelbaum PC.
    Antimicrob Agents Chemother; 2008 Jan 15; 52(1):333-6. PubMed ID: 17967915
    [Abstract] [Full Text] [Related]

  • 31. In vitro and in vivo evaluation of BO-2727 against imipenem- and/or meropenem-resistant Pseudomonas aeruginosa.
    Shibata K, Adachi Y, Kato E, Nagano R, Fuse A, Hashizume T, Ohtake N, Okamoto O, Nakagawa S.
    J Antibiot (Tokyo); 1997 Feb 15; 50(2):135-8. PubMed ID: 9099222
    [Abstract] [Full Text] [Related]

  • 32. In-vitro efficacy of synergistic antibiotic combinations in multidrug resistant Pseudomonas aeruginosa strains.
    Dundar D, Otkun M.
    Yonsei Med J; 2010 Jan 15; 51(1):111-6. PubMed ID: 20046523
    [Abstract] [Full Text] [Related]

  • 33. Is levofloxacin as active as ciprofloxacin against Pseudomonas aeruginosa?
    Bonfiglio G.
    Chemotherapy; 2001 Jan 15; 47(4):239-42. PubMed ID: 11399859
    [Abstract] [Full Text] [Related]

  • 34. Spectrum and activity of three contemporary fluoroquinolones tested against Pseudomonas aeruginosa isolates from urinary tract infections in the SENTRY Antimicrobial Surveillance Program (Europe and the Americas; 2000): more alike than different!
    Jones RN, Beach ML, Pfaller MA.
    Diagn Microbiol Infect Dis; 2001 Nov 15; 41(3):161-3. PubMed ID: 11750171
    [Abstract] [Full Text] [Related]

  • 35. Combined effects of the siderophore monosulfactam BAL30072 and carbapenems on multidrug-resistant Gram-negative bacilli.
    Hofer B, Dantier C, Gebhardt K, Desarbre E, Schmitt-Hoffmann A, Page MG.
    J Antimicrob Chemother; 2013 May 15; 68(5):1120-9. PubMed ID: 23344577
    [Abstract] [Full Text] [Related]

  • 36. In vitro efficacy of various antibiotic combinations against Pseudomonas aeruginosa isolates.
    Nazli E, Zer Y, Eksi F.
    J Int Med Res; 2015 Apr 15; 43(2):217-25. PubMed ID: 25547417
    [Abstract] [Full Text] [Related]

  • 37. Investigation into the selection frequency of resistant mutants and the bacterial kill rate by levofloxacin and ciprofloxacin in non-mucoid Pseudomonas aeruginosa isolates from cystic fibrosis patients.
    Gillespie T, Masterton RG.
    Int J Antimicrob Agents; 2002 May 15; 19(5):377-82. PubMed ID: 12007845
    [Abstract] [Full Text] [Related]

  • 38. Predicting doripenem susceptibility based on meropenem and imipenem interpretation for Pseudomonas aeruginosa.
    Hagihara M, Kuti JL, Nicolau DP.
    Diagn Microbiol Infect Dis; 2012 Mar 15; 72(3):258-62. PubMed ID: 22209563
    [Abstract] [Full Text] [Related]

  • 39. Imipenem and meropenem induced resistance to beta-lactam antibiotics in Pseudomonas aeruginosa.
    Giacometti A, Siquini FM, Cirioni O, Petroni S, Scalise G.
    Eur J Clin Microbiol Infect Dis; 1994 Apr 15; 13(4):315-8. PubMed ID: 8070438
    [Abstract] [Full Text] [Related]

  • 40. Comparative activity of meropenem against Pseudomonas aeruginosa strains with well-characterized resistance mechanisms.
    Livermore DM, Yang YJ.
    J Antimicrob Chemother; 1989 Sep 15; 24 Suppl A():149-59. PubMed ID: 2553657
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.